Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Medicine|May 15, 2009
Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromesVicente F Corrales-Medina, Jose Serpa, Adriana M Rueda, et al.
The American Journal of Tropical Medicine and Hygiene|April 7, 2009
Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, TexasKaren J Vigil, Zhi-Dong Jiang, Jaclyn J Chen, et al.
FEMS Immunology and Medical Microbiology|July 13, 2006
Clostridium difficile lacks detectable superantigen activityAnna Wanahita, Beckley Davis, Richard J Hamill, et al.
Plos One|October 20, 2012
Genome analysis of a highly virulent serotype 1 strain of Streptococcus pneumoniae from West AfricaTiffany M Williams, Nicholas J Loman, Chinelo Ebruke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapyOmar Y Gonzalez, Daniel M Musher, Indira Brar, et al.
The European Respiratory Journal|May 14, 2016
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumoniaRosanel Amaro, Adamantia Liapikou, Catia Cilloniz, et al.
Medicine|October 8, 2003
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter studyFeng-Yee Chang, James E Peacock, Daniel M Musher, et al.
Medicine|October 8, 2003
A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistanceFeng-Yee Chang, Brent B MacDonald, James E Peacock, et al.
Human Vaccines|August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adultsDaniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
The Journal of Infectious Diseases|January 23, 2010
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adultsDaniel M Musher, Susan B Manof, Charlie Liss, et al.
Pageof 12